Chengdu Kanghong Pharmaceutical Group Co., Ltd
SHZ: 002773.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Xiao Ke
- Employees
- 4,462
- Headquarters
- Chengdu, China
- IPO year
- 2015
- Market cap
- CN¥22.3B
- Website
- https://www.cnkh.com
Loading 002773…
Loading profile data…Frequently asked questions about 002773
What does Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) do?
Chengdu Kanghong Pharmaceuticals Group Co., Ltd engages in the research, development, production, and sale of biological products, Chinese medicines, and chemical drugs in China. It offers ophthalmic systems, central nervous systems, digestive systems, and other system drugs. The company was founded in 1996 and is headquartered in Chengdu, China.
Where does 002773.SZ trade?
Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002773.SZ in?
Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Chengdu Kanghong Pharmaceutical Group Co., Ltd?
Xiao Ke is the chief executive officer of Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ).
Where is Chengdu Kanghong Pharmaceutical Group Co., Ltd headquartered?
Chengdu Kanghong Pharmaceutical Group Co., Ltd is headquartered in China.
Does 002773.SZ pay a dividend?
Yes — Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) paid a trailing twelve-month dividend of CNY 0.60 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002773.SZ go public?
Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) completed its initial public offering in 2015.